Inhibition of Src with AZD0530 Reveals the Src-Focal Adhesion Kinase Complex as a Novel Therapeutic Target in Papillary and Anaplastic Thyroid CancerRebecca E. Schweppe, Bryan R. Haugen|The Journal of Clinical Endocrinology & Metabolism|2009Cited by 65
Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–Resistant MelanomaKelsey W. Nassar, Rebecca E. Schweppe|Molecular Cancer Therapeutics|2021Cited by 37
The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapiesHannah M. Hicks, Rebecca E. Schweppe|Cancer Biology & Therapy|2024Cited by 7